Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanjing Peptide Biotech specializes in the custom synthesis of peptides, amino acids, their derivatives, peptide intermediates for pharmaceuticals and cosmetics, as well as related reagents. The company provides products and technical services to pharmaceutical companies, universities, research institutes, and drug development organizations. It does not develop its own therapeutic pipeline but supports R&D across the life sciences sector with high-quality synthetic peptides and related materials.
No clinical results or proprietary drug programs are reported.
The company operates advanced facilities capable of producing up to 2000 peptide batches per month.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nanjing Peptide Biotech.